Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Countdown to Organon (OGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 28'th Apr 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Organon (OGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Organon (OGN) Ascends But Remains Behind Market: Some Facts to Note
07:05pm, Friday, 25'th Apr 2025
In the most recent trading session, Organon (OGN) closed at $12.20, indicating a +0.66% shift from the previous trading day.
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 25'th Apr 2025
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 24'th Apr 2025
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon Appoints Ramona A. Sequeira to the Company's Board of Directors
05:00pm, Tuesday, 15'th Apr 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces the appointment of Ramona A. Sequeira to the company's Board of Directors, effective July 1, 2025.
Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025
07:31am, Tuesday, 15'th Apr 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon will host Q1 2025 earnings results webcast and conference call on May 1, 2025.
Organon (OGN) Laps the Stock Market: Here's Why
07:05pm, Monday, 14'th Apr 2025
Organon (OGN) closed the most recent trading day at $11.30, moving +1.07% from the previous trading session.
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
10:00am, Monday, 14'th Apr 2025
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Strength Seen in Organon (OGN): Can Its 8.5% Jump Turn into More Strength?
10:15am, Thursday, 10'th Apr 2025
Organon (OGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Thursday, 03'rd Apr 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Organon (OGN) Could Beat Earnings Estimates Again
01:15pm, Wednesday, 02'nd Apr 2025
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
10:00am, Tuesday, 01'st Apr 2025
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announced it has acquired regulatory and commercial rights in the U.S. for TOFIDENCE™, a biosimilar to ACTEMRA®, for intravenous infusion.
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
06:00am, Friday, 28'th Mar 2025
SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Henlius and Organon announced the European Medicines Agency validates filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11.
Organon (OGN) Falls More Steeply Than Broader Market: What Investors Need to Know
07:05pm, Thursday, 27'th Mar 2025
Organon (OGN) closed the most recent trading day at $14.56, moving -1.02% from the previous trading session.
